The dividend headlines treat KO as a slow-growth defensive. The 38% jump in operating income, the Marriott commercial win, and the fairlife capacity expansion tell a different story.
Coca-Cola is not a 2-3% organic growth stock anymore. The trailing operating income line says so cleanly. KO printed $13.8 billion of operating income in 2025, up 38% from $10.0 billion in 2024 and well above the $11.3 billion reported in 2023. That is not a margin reversion; it is a step-change in the underlying earnings power of the business.
The consensus reaction to KO has been muted. The stock trades at $326 billion of market cap, a forward P/E of 23.4, and a 2.71% dividend yield, with a 50-day moving average of $77.54 against a 200-day of $71.62. The chart looks like a textbook defensive in a slow grind. The fundamentals look like a business that has reset its category mix and is now harvesting structurally higher margins.
The Signals Desk reads this as a case where the operating data is leading the price. Below are five distinct signals from the 2024-2026 reporting period that, taken together, support a thesis that the consensus 2027 EPS walk is too low by 5-7%. We build the cumulative case across five points.
The Signals Desk track record on multi-signal listicles has been that three out of five signals holding for two consecutive quarters typically precedes a re-rate by three to six months. The current cycle sits at signal count four of five holding, with the fifth (margin durability) requiring one more quarter of data to confirm. That is the set-up. The data point that would invalidate the thesis is a second consecutive quarter of operating margin regression below 24%. Without that, the trajectory holds. With it, the signals collapse. The distribution is asymmetric in favour of the former.
The headline number is the cleanest signal. Volume growth in 2025 ran at a global organic 2-3%, broadly in line with the historical norm. Operating income jumped 38%. The math says the incremental contribution per case has accelerated meaningfully, driven by mix shift toward higher-margin categories (zero-sugar, premium water, alternative dairy) and a structural improvement in the bottler-system economics following the system-wide refranchising.
The signal here is that KO has decoupled top-line volume growth from operating income growth. That decoupling is not transitory; it reflects a portfolio that earns more per case than it did three years ago. The forward operating income trajectory should compound at a rate above volume growth for the next several reporting periods, which is the foundational assumption that the consensus model is not yet pricing.
Historically, beverage companies that have decoupled volume from operating income in this manner have re-rated by 100-200 basis points of forward multiple. PepsiCo did so in the 2010-2014 window. Constellation Brands did so in 2017-2020. KO's setup looks closer to the 2017-2020 Constellation analogue.
The pricing component of this step matters. KO raised price/mix by approximately 6% across global operating units in 2025 while holding volume growth at 2-3%. The elasticity has held better than peer companies like Constellation Brands (which saw a volume softness on similar price actions) and PepsiCo (which has seen some category-specific volume pushback). That combination (stable volume, solid price/mix, margin accretion) is the kind of operating signature that precedes a re-rate, not that follows one.
TickerXray Report
Get the complete Coca-Cola report with all 12 quantitative models, AI-generated investment thesis, and real-time data.
Coca-Cola's recent contract win at Marriott (replacing Pepsi across thousands of properties) is the kind of foodservice channel anchor that compounds over a multi-year window. The headline value of the contract is not the right way to size it. The right way is to think about the cross-portfolio pull-through from a single anchor account: every sparkling drink, every coffee, every juice, every water serving rolls through the Coca-Cola product set across the contract life.
For the foodservice channel specifically, anchor wins on this scale have historically translated to 3-5% incremental segment revenue over a four-year ramp, with above-corporate-average gross margins because foodservice pricing is dollar-per-pour rather than dollar-per-case. The Marriott win on its own does not move the consolidated revenue line by more than 50-80 basis points. It does, however, signal a competitive momentum shift that historically precedes a string of similar wins. This pattern was visible in the data after Coca-Cola's prior anchor wins (Wendy's, Subway expansion). Watch for two or three additional foodservice anchors over the next eighteen months.
A second way to frame the Marriott signal: in foodservice win economics, a large anchor typically triggers rebid activity across adjacent accounts within 12-18 months. Hotel chains and restaurant groups watch these decisions and often follow the leader to capture similar volume discounts or portfolio breadth. The domino pattern, when it plays out, can add another 1-2% of channel-level revenue over 24 months. The Signals Desk expects to see at least two additional announcements in this channel before year-end 2026.
fairlife is the lactose-free premium dairy brand that has grown from a $500 million curiosity in 2017 to a $4 billion-plus revenue contributor today. The April 2026 capacity expansion announcement (additional production lines in Texas and accelerated build-out in the Mid-Atlantic) addresses what has been the binding constraint on the brand's growth: not consumer demand, but production capacity.
With capacity loosening, fairlife revenue should accelerate from a trailing 18-22% growth rate to a 22-28% growth rate over the next two reporting periods. On a $4 billion base, that incremental growth is worth $700-900 million of incremental revenue annually, with operating margins above the corporate average. The fairlife contribution alone is worth roughly 1.5% of consolidated organic growth in FY2026. Consensus models have not fully baked this in; the capacity announcement post-dates the most recent round of sell-side updates.
The brand's competitive position is also worth noting. fairlife operates in a premium dairy category where the closest competitor (Chobani) plays in adjacent rather than directly overlapping segments. Pricing power has remained robust through 2025 despite broader inflation in the dairy input cost stack. Gross margins on incremental volume are accreting, not compressing.
There is a strategic read on the fairlife expansion that matters beyond the numbers. The brand's penetration is still well below its theoretical ceiling. Household penetration in premium dairy sits at 25-30% in core markets, well below the 45-55% levels that mature categories eventually reach. The capacity investment is not a response to saturation; it is a response to a penetration curve that is still in its middle innings. That dynamic matters for the durability of the growth rate beyond 2027.
Bears point to the FCF line as a sign of trouble. FCF dropped from $11.3 billion in 2021 to $4.7 billion in 2024 and $5.3 billion in 2025. On the surface, that is a 53% compression. The decomposition is more reassuring.
The 2024 FCF compression was driven by three factors: a one-time IRS payment related to a long-running tax dispute, working-capital investment to support the fairlife capacity expansion, and elevated capex on bottling investments in India and Africa. The first is non-recurring. The second is investment in capacity that is now beginning to convert to revenue (see signal 3). The third is part of a deliberate emerging-market expansion program that has a clear payback profile.
Normalised FCF (stripping out the IRS payment and adjusting capex to a steady-state level) sits in the $9-11 billion range, against a market cap of $326 billion. That is a 3-3.5% FCF yield, slightly below the historical average but not dramatically so. As capex normalises in 2027, the reported FCF figure should rebuild back toward $9-10 billion, and the yield argument resumes. The compression is a multi-year investment cycle, not a deterioration in earnings quality.
The working capital investment inside the FCF line deserves a separate mention. Inventory build for the Indian bottling investments absorbed roughly $1.2 billion of working capital in 2024 and another $800 million in 2025. That investment is a one-off; once the Indian production lines reach steady-state, the inventory intensity of the business reverts to the pre-investment norm. The $2 billion of cumulative absorption is a short-duration effect that will release as a tailwind over 2026-2027.
Across the 2021-2025 window, KO's operating margin has compressed from 27% to 21% and back to 28.7%. The 2025 print is the highest in the data series. That margin level has historically been associated with the mid-cycle peaks that the company has briefly touched, not held.
The Signals Desk position is that the 2025 margin is closer to a new normal than to a cyclical peak. Three structural drivers support that view: the post-refranchising bottler economics now contribute a higher share of operating income at lower fixed-cost intensity; the mix shift toward zero-sugar and premium water carries a 200-300 basis point gross margin advantage versus traditional carbonated; and the Costa Coffee build-out (acquired in 2018) has finally crossed the operating income breakeven at scale.
If the 28% operating margin holds through 2026 and 2027, even with modest volume growth of 3-4%, the implied FY2027 operating income is $15-16 billion, against current consensus of approximately $14 billion. That is the 5-7% gap that we believe the market is mispricing. At a 23x forward multiple, the gap is worth roughly $9 of fair value, taking the stock from $76 to $85.
Historically, beverage majors that have produced two consecutive years of operating margin above their 5-year average have re-rated within 12-18 months. KO's first year is in the books. The second is the catalyst.
One further angle on the margin story. Costa Coffee, acquired in 2018, was a drag on operating margin for the first five years post-close. The UK hospitality sector faced pandemic disruption, reopening costs, and energy-cost inflation that pushed the brand's contribution below breakeven. The 2025 print showed Costa contributing positively for the full year, with approximately 200 basis points of operating margin at scale. That transition from drag to accretion alone is worth 40-60 basis points of consolidated margin improvement.
Consider also the longer history. Between 2005 and 2015, KO's operating margin oscillated in a 21-24% range. Between 2015 and 2020, the range shifted to 23-28% following the early-stage portfolio refranchising. The 2025 print at 28.7% represents the highest observation in the entire 20-year data series. If the next-cycle range shifts up by 200-300 basis points versus the 2015-2020 baseline, the implied steady-state EBIT runs at $15-17 billion by 2028, materially above consensus.
Two risks are worth flagging. First, FX. A strong dollar cycle compresses KO's reported international revenue and operating income. Roughly 65% of KO's revenue is generated outside the US. A 5-8% USD appreciation would shave 2-3% off the reported 2027 earnings walk. The underlying economics are unchanged, but the reported numbers are sensitive to the dollar.
Second, category risk. GLP-1 medication adoption has been the structural narrative bear case on beverage majors for two years. The empirical data has been surprisingly benign so far: KO's volume growth has held through the first wave of GLP-1 adoption, and the mix shift toward zero-sugar suggests that consumer substitution has flowed within the KO portfolio rather than out of it. The risk is not zero but the evidence is not currently pointing at a structural demand reset. A reacceleration of GLP-1 prescription growth paired with a shift toward fat-loss injectables across younger demographics would be the scenario to watch.
Neither risk breaks the five signals. Both adjust the trajectory at the margin. Position sizing should reflect the FX cycle specifically; a fully-hedged position would add cost without meaningfully changing the economic exposure.
Take the five signals together. Operating income decoupled from volume. The Marriott win signals competitive momentum in foodservice. fairlife capacity loosens the binding constraint on premium dairy. Free cash flow compression is cyclical investment, not structural. Operating margin is at a new structural normal rather than a cyclical peak.
None of those five points individually is a catalyst. Together, they support a fair value of $85-90, against a current price of roughly $76. The 12-month target is $87. The bear case floor at 20x forward earnings is $66, implying 13% downside against 12-15% upside. That is balanced asymmetry.
The trade is to hold existing positions and accumulate on any pullback below $74. The dividend yield of 2.7% provides a carry floor while the thesis matures. The catalyst calendar runs: Q1 print confirmation of the operating margin trajectory, Q2 update on fairlife capacity ramp, additional foodservice anchor announcements, and the 2027 preliminary guide. Two confirmations in that calendar accelerate the re-rate. The signals say the trajectory is intact.
The Signals Desk rates this a high-conviction positioning call with a modest time horizon. The re-rate does not require a single spectacular catalyst; it requires the continuation of the five signals already in motion. That is the type of trade where patience has historically paid and speculation has historically been punished.
Full forensic analysis of Coca-Cola
+ 6 more models included
150,000+ stocks covered
Global coverage across 60+ exchanges. Every report includes all 12 quantitative models and AI analysis.
View plansEvery report runs 12 quantitative models and generates an AI investment thesis. From Piotroski scores to manipulation detection -- get the full picture in seconds.
12 forensic models
Piotroski, Altman, Beneish, DuPont & more
AI investment thesis
Synthesized outlook on every stock
Manipulation detection
Spot red flags before they hit the news
150,000+ tickers
Global coverage across 60+ exchanges
Expected return
Forward return projections for every stock
Real-time data
Live prices, insider trades, news sentiment
Free accounts get 1 report per month. Pro gets unlimited.
The consensus view is that Coca-Cola's price/mix engine has run its course. The data on emerging markets, away-from-home channel recovery, and the Fairlife premium portfolio says the next leg has barely started.
The capital allocation framework that Warren Buffett endorsed for 37 years has produced 5.8% per-share dividend growth compounded. The analytical take on whether the framework still fits.
Coca-Cola's 27% margins and 25%+ ROIC versus P&G's lower valuation and broader diversification. A head-to-head comparison of capital allocation quality in consumer staples.